ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,774, issued on Jan. 20, was assigned to LEAD PHARMA HOLDING B.V. (Oss, Netherlands).
"Estrogen-related receptor alpha modulators" was invented by Jaap Gerardus Henricus Lemmers (Oss, Netherlands), Eugen Deretey (Oss, Netherlands), Johannes Petrus Gerardus Klomp (Oss, Netherlands), Joseph Maria Gerardus Barbara Cals (Oss, Netherlands) and Arthur Oubrie (Oss, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to compounds according to Formula I and the pharmaceutically acceptable salts thereof. The compounds can be used as modulators of Estrogen-related Receptor alpha (ERRAlpha) and have utility in the treatme...